BlueCrest Capital Management’s Bruker BRKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-2,900
Closed -$229K – 211
2023
Q1
$229K Buy
+2,900
New +$209K 0.01% 243
2018
Q4
– Sell
-9,076
Closed -$304K – 902
2018
Q3
$304K Buy
+9,076
New +$299K 0.01% 1034
2018
Q1
– Sell
-19,977
Closed -$686K – 1486
2017
Q4
$686K Buy
+19,977
New +$654K 0.02% 458
2017
Q3
– Sell
-40,714
Closed -$1.17M – 860
2017
Q2
$1.17M Buy
+40,714
New +$1.05M 0.05% 438
2016
Q2
– Sell
-30,000
Closed -$840K – 865
2016
Q1
$840K Sell
30,000
-323,152
-92% -$8.06M 0.05% 407
2015
Q4
$8.57M Buy
+353,152
New +$7.33M 0.36% 31

Other funds holding BRKR

BlueCrest Capital Management's BRKR Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Bruker (BRKR) in Q2 2023, closing a stake of 2,900 shares — an estimated $229K sold.

BlueCrest Capital Management first reported a position in BRKR in Q4 2015 and held it in 6 quarters. The position peaked at $8.57M in Q4 2015. 357 funds tracked by Wall St. Rank hold BRKR as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Bruker position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 2,900 Bruker shares in Q2 2023, an estimated $229K.
  • BlueCrest Capital Management first reported a position in Bruker in Q4 2015 and held it in 6 quarters.
  • BlueCrest Capital Management's Bruker position peaked at $8.57M in Q4 2015.
  • 357 funds tracked by Wall St. Rank held Bruker as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.